Supply disruption with Harvoni 45 mg/200 mg film-coated tablets (ledipasvir/sofosbuvir) in the UK

An Irish Import has been approved for use by the MHRA and is expected to be on the UK market until 31st December to cover the shortage. The product has the same formulation as the UK product though there are minor differences in the product information.

Source:

Gilead Sciences Inc.